The long-term changes in coping strategies in schizophrenia: temporal coping types

The Journal of Nervous and Mental Disease
Michael S Ritsner, Yael Ratner

Abstract

This prospective study aimed to define the long-term changes in coping strategies used by schizophrenia patients and their relation to clinical and psychosocial factors. The Coping Inventory for Stressful Situations, psychiatric scales, and self-report questionnaires were administered to 148 schizophrenia patients at admission and 16 months thereafter. Based on trends of individual coping patterns to show change over time, four temporal coping types were distinguished: stable favorable and unfavorable, and becoming favorable and unfavorable. We found that coping patterns of 62.2% of patients remained stable over time, became unfavorable among 19.6% of patients, and became favorable among 18.2% of patients. Each temporal coping type is associated with a specific pattern of changes in clinical and psychosocial variables. The findings underscore the clinical relevance of temporal coping types and corroborate the appropriateness of focusing on aspects of coping behavior in treatment and rehabilitation of schizophrenia patients.

References

May 1, 1990·Journal of Personality and Social Psychology·N S Endler, J D Parker
Dec 1, 1988·The British Journal of Medical Psychology·V Carr
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Aug 1, 1987·Journal of Personality and Social Psychology·C M Aldwin, T A Revenson
Mar 1, 1995·Psychiatric Services : a Journal of the American Psychiatric Association·D H Hughes
Aug 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·P W LeeJ A Spinks
Nov 1, 1995·Psychiatric Services : a Journal of the American Psychiatric Association·P Solomon, J Draine
Dec 24, 1997·Comprehensive Psychiatry·R J van den Bosch, R P Rombouts
Jan 5, 1999·Psychotherapy and Psychosomatics·T UeharaT Someya
Jul 30, 1999·The Journal of Nervous and Mental Disease·T LecomteN Ricard
May 29, 2000·The American Journal of Orthopsychiatry·S BoschiN Galambos
Jul 13, 2000·The American Psychologist·R S Lazarus
Sep 19, 2000·Schizophrenia Bulletin·J P SeltenR J van den Bosch
Aug 16, 2001·The Journal of Nervous and Mental Disease·P H LysakerK A Marks
Jan 15, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michael RitsnerIlan Modai
May 8, 2002·Comprehensive Psychiatry·Michael RitsnerAlexander Ponizovsky
Jun 6, 2002·Schizophrenia Research·Kelly E Wilder-WillisJoyce Borkin
Sep 11, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M RitsnerI Modai
Mar 11, 2003·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M RitsnerI Modai
Apr 29, 2003·The Journal of Clinical Psychiatry·Michael RitsnerYael Ratner
Jul 1, 1965·Journal of Clinical Psychology·L A ROSENBERG, A M ROSENBERG
Oct 14, 2003·The Journal of Nervous and Mental Disease·Michael RitsnerAnatoly Gibel
Jul 16, 2005·Comprehensive Psychiatry·Rael D StrousMichael Ritsner

❮ Previous
Next ❯

Citations

Apr 3, 2014·BMC Psychiatry·Johanna T W WigmanMary Cannon
Jun 2, 2012·Psychopathology·Sarah RücklKlaus-Thomas Kronmüller
Oct 3, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Silvana GalderisiUNKNOWN Italian Network For Research on Psychoses
Jul 19, 2019·Early Intervention in Psychiatry·Itziar Riera-López de AguiletaSusana Ochoa
Feb 7, 2008·Santé mentale au Québec·Yves LecomteSuzane Renaud

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.